Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (19)

1

Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients : The Italian VAX4FRAIL Study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Corradini, P. | Agrati, C. | Apolone, G. | +125

2

A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma

enthalten in: Hematological oncology | 2023

von Carlo-Stella, C. | Zinzani, P. | Sureda, A. | +22

3

Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma : results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

enthalten in: Annals of hematology | 2021

von Santoro, A. | Mazza, R. | Spina, M. | +24

4

A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma

enthalten in: Investigational new drugs | 2021

von Balzarotti, M. | Magagnoli, M. | Canales, M. | +8

5

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2) : a multicentre, open-label, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Caimi, P. | Ai, W. | Alderuccio, J. | +15

CommentIn: Lancet Oncol. 2021 Jun;22(6):741-742. - PMID 33989556

6

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma : A Phase I Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Hutchings, M. | Morschhauser, F. | Iacoboni, G. | +20

CommentIn: Nat Rev Clin Oncol. 2021 May;18(5):257. - PMID 33828233

7

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

enthalten in: Blood | 2021

von Hamadani, M. | Radford, J. | Carlo-Stella, C. | +14

CommentIn: Blood. 2021 May 13;137(19):2568-2570. - PMID 33983420

8

Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas

enthalten in: Transplantation and cellular therapy | 2021

von Castagna, L. | Dodero, A. | Patriarca, F. | +13

9

A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies : Results From the European Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Carlo-Stella, C. | Delarue, R. | Scarfo, L. | +8

10

A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kahl, B. | Hamadani, M. | Radford, J. | +12